Cellular localization and antiproliferative effect of peptides discovered from a functional screen of a retrovirally delivered random peptide library

Chemistry and Biology

Volumn 10, Issue 10, 2003, Pages 975-987

  Hitoshi, Yasumichi ^a   Gururaja, Tarikere ^a   Pearsall, Denise M ^a   Lang, Wayne ^a   Sharma, Poonam ^a   Huang, Betty ^a   Catalano, Susan M ^a   McLaughlin, John ^a   Pali, Erlina ^a   Peelle, Beau ^a,c   Vialard, Jorge ^b   Janicot, Michel ^b   Wouters, Walter ^b   Luyten, Walter ^b,d   Bennett, Mark K ^a   Anderson, Dave C ^a,e   Payan, Donald G ^a   Lorens, James B ^a   Bogenberger, Jacob ^a   Demo, Susan ^a  

^a RIGEL PHARMACEUTICALS INC   (United States)

^b JANSSEN RESEARCH AND DEVELOPMENT   (Belgium)

^c MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^d PharmaDM   (Belgium)

^e UNIVERSITY OF OREGON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 10744225311     PISSN: 10745521     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.chembiol.2003.09.009     Document Type: Article

References (33)

1. Springett G.M., Moen R.C., Anderson S., Blaese R.M., Anderson W.F. Infection efficiency of T lymphocytes with amphotropic retroviral vectors is cell cycle dependent. J. Virol. 63:1989;3865-3869.
2. Batra R.K., Olsen J.C., Pickles R.J., Hoganson D.K., Boucher R.C. Transduction of non-small cell lung cancer cells by adenoviral and retroviral vectors. Am. J. Respir. Cell Mol. Biol. 18:1998;402-410.
3. Hitoshi Y., Lorens J., Kitada S.I., Fisher J., LaBarge M., Ring H.Z., Francke U., Reed J.C., Kinoshita S., Nolan G.P. Toso, a cell surface, specific regulator of Fas-induced apoptosis in T cells. Immunity. 8:1998;461-471.
4. Xu X., Leo C., Jang Y., Chan E., Padilla D., Huang B.C., Lin T., Gururaja T., Hitoshi Y., Lorens J.B.et al. Dominant effector genetics in mammalian cells. Nat. Genet. 27:2001;23-29.
5. Lorens J.B., Sousa C., Bennett M.K., Molineaux S.M., Payan D.G. The use of retroviruses as pharmaceutical tools for target discovery and validation in the field of functional genomics. Curr. Opin. Biotechnol. 12:2001;613-621.
6. Perez O.D., Kinoshita S., Hitoshi Y., Payan D.G., Kitamura T., Nolan G.P., Lorens J.B. Activation of the PKB/AKT pathway by ICAM-2. Immunity. 16:2002;51-65.
7. Kinsella T.M., Ohashi C.T., Harder A.G., Yam G.C., Li W., Peelle B., Pali E.S., Bennett M.K., Molineaux S.M., Anderson D.A.et al. Retrovirally delivered random cyclic peptide libraries yield inhibitors of interleukin-4 signaling in human B cells. J. Biol. Chem. 277:2002;37512-37518.
8. Peelle B., Lorens J., Li W., Bogenberger J., Payan D.G., Anderson D.C. Intracellular protein scaffold-mediated display of random peptide libraries for phenotypic screens in mammalian cells. Chem. Biol. 8:2001;521-534.
9. Colas P., Cohen B., Jessen T., Grishina I., McCoy J., Brent R. Genetic selection of peptide aptamers that recognize and inhibit cyclin-dependent kinase 2. Nature. 380:1996;548-550.
10. Abedi M.R., Caponigro G., Kamb A. Green fluorescent protein as a scaffold for intracellular presentation of peptides. Nucleic Acids Res. 26:1998;623-630.
11. Norman T.C., Smith D.L., Sorger P.K., Drees B.L., O'Rourke S.M., Hughes T.R., Roberts C.J., Friend S.H., Fields S., Murray A.W.et al. Genetic selection of peptide inhibitors of biological pathways. Science. 285:1999;591-595.
12. Lorens J.B., Bennett M.K., Pearsall D.M., Throndset W.R., Rossi A.B., Armstrong R.J., Fox B.P., Chan E.H., Luo Y., Masuda E.et al. Retroviral delivery of peptide modulators of cellular functions. Mol. Ther. 1:2000;438-447.
13. Mattock H., Lane D.P., Warbrick E. Inhibition of cell proliferation by the PCNA-binding region of p21 expressed as a GFP miniprotein. Exp. Cell Res. 265:2001;234-241.
14. Warbrick E., Lane D.P., Glover D.M., Cox L.S. A small peptide inhibitor of DNA replication defines the site of interaction between the cyclin-dependent kinase inhibitor p21WAF1 and proliferating cell nuclear antigen. Curr. Biol. 5:1995;275-282.
15. Picksley S.M., Vojtesek B., Sparks A., Lane D.P. Immunochemical analysis of the interaction of p53 with MDM2 - fine mapping of the MDM2 binding site on p53 using synthetic peptides. Oncogene. 9:1994;2523-2529.
16. Yuan J., Kramer A., Eckerdt F., Kaufmann M., Strebhardt K. Efficient internalization of the polo-box of polo-like kinase 1 fused to an Antennapedia peptide results in inhibition of cancer cell proliferation. Cancer Res. 62:2002;4186-4190.
17. Schaber M.D., O'Hara M.B., Garsky V.M., Mosser S.C., Bergstrom J.D., Moores S.L., Marshall M.S., Friedman P.A., Dixon R.A., Gibbs J.B.et al. Polyisoprenylation of Ras in vitro by a farnesyl-protein transferase. J. Biol. Chem. 265:1990;14701-14704.
18. Hancock J.F., Cadwallader K., Paterson H., Marshall C.J. A CAAX or a CAAL motif and a second signal are sufficient for plasma membrane targeting of ras proteins. EMBO J. 10:1991;4033-4039.
19. Fu H.W., Casey P.J. Enzymology and biology of CaaX protein prenylation. Recent Prog. Horm. Res. 54:1999;315-342. ; discussion 342-313.
20. Yamane H.K., Farnsworth C.C., Xie H.Y., Evans T., Howald W.N., Gelb M.H., Glomset J.A., Clarke S., Fung B.K. Membrane-binding domain of the small G protein G25K contains an S-(all-trans-geranylgeranyl)cysteine methyl ester at its carboxyl terminus. Proc. Natl. Acad. Sci. USA. 88:1991;286-290.
21. Yoneda Y., Hieda M., Nagoshi E., Miyamoto Y. Nucleocytoplasmic protein transport and recycling of Ran. Cell Struct. Funct. 24:1999;425-433.
22. Henderson B.R., Eleftheriou A. A comparison of the activity, sequence specificity, and CRM1-dependence of different nuclear export signals. Exp. Cell Res. 256:2000;213-224.
23. Chook Y.M., Blobel G. Karyopherins and nuclear import. Curr. Opin. Struct. Biol. 11:2001;703-715.
24. Vives E., Brodin P., Lebleu B. A truncated HIV-1 Tat protein basic domain rapidly translocates through the plasma membrane and accumulates in the cell nucleus. J. Biol. Chem. 272:1997;16010-16017.
25. Futaki S., Suzuki T., Ohashi W., Yagami T., Tanaka S., Ueda K., Sugiura Y. Arginine-rich peptides. An abundant source of membrane-permeable peptides having potential as carriers for intracellular protein delivery. J. Biol. Chem. 276:2001;5836-5840.
26. Lindsay M.A. Peptide-mediated cell delivery. application in protein target validation Curr. Opin. Pharmacol. 2:2002;587-594.
27. Gururaja T.L., Li W., Payan D.G., Anderson D.C. Utility of peptide-protein affinity complexes in proteomics. identification of interaction partners of a tumor suppressor peptide J. Pept. Res. 61:2003;163-176.
28. Kirchhausen T. Clathrin adaptors really adapt. Cell. 109:2002;413-416.
29. Royle S.J., Murrell-Lagnado R.D. Constitutive cycling. a general mechanism to regulate cell surface proteins Bioessays. 25:2003;39-46.
30. Kirchhausen T. Clathrin. Annu. Rev. Biochem. 69:2000;699-727.
31. Lafer E.M. Clathrin-protein interactions. Traffic. 3:2002;513-520.
32. Lorens J.B., Jang Y., Rossi A.B., Payan D.G., Bogenberger J.M. Optimization of regulated LTR-mediated expression. Virology. 272:2000;7-15.
33. Swift S., Lorens J., Achacoso P., Nolan G.P. Rapid production of retroviruses for efficient gene delivery to mammalin cells using 293T cell-based systems. Coligan J.E., Kruisbeek A.M., Margulies D.H., Shevach E.M., Strober W. Current Protocols in Immunology. 1999;Wiley & Sons, New York. , Chapter 10, Section VI, Unit 10.17C.